Skip to content

Evaluation of the Effectiveness of the Ezisurg Stapling (Ezi Endo Lite) During Laparoscopic Nissen Sleeve Gastrectomy

Evaluation of the Effectiveness of the Ezisurg Stapling (Ezi Endo Lite) During Laparoscopic Nissen Sleeve Gastrectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07344935
Enrollment
167
Registered
2026-01-15
Start date
2022-01-01
Completion date
2025-07-01
Last updated
2026-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal Reflux Disease (GERD)

Brief summary

The Nissen Sleeve technique consists of creating a gastric total fundoplication (Nissen technique) before to perform the removal of 2/3 of the stomach (SLEEVE technique), intends for decrease the rate of gastroesophageal reflux disease (GERD). This study aims to evaluate the influence of the Nissen Sleeve technique on GERD. However, the Ezisurg easyEndoTM Linear Cutting Stapler and Loading Units for Single Use were used in this study, and its safety and performance could be evaluated at the same time.

Interventions

PROCEDUREEzisurg stapler SLEEVE technique

The Nissen Sleeve technique consists of creating a gastric total fundoplication (Nissen technique) before to perform the removal of 2/3 of the stomach (SLEEVE technique)

PROCEDUREEthicon Stapler SLEEVE technique

The Nissen Sleeve technique consists of creating a gastric total fundoplication (Nissen technique) before to perform the removal of 2/3 of the stomach (SLEEVE technique)

Sponsors

University Hospital, Montpellier
CollaboratorOTHER
Ezisurg Medical Co. Ltd.
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Body Mass Index (BMI) ≥ 30 kg/m² (or BMI ≥ 27 kg/m² with at least one obesity-related comorbidity, e.g., type 2 diabetes, hypertension, dyslipidemia). * Medically eligible for laparoscopic sleeve gastrectomy (LSG) or Nissan sleeve surgery, as determined by a multidisciplinary bariatric team (e.g., surgeon, endocrinologist, dietitian). * Ability to understand and voluntarily sign written informed consent. * Willingness to comply with post-operative follow-up protocols (e.g., dietary monitoring, clinical visits, laboratory tests).

Exclusion criteria

* BMI \< 30 kg/m² (or \< 27 kg/m² without obesity-related comorbidities). * Contraindications to laparoscopic surgery (e.g., severe abdominal adhesions, hemodynamic instability, uncorrected coagulopathy). * History of major gastrointestinal surgery (e.g., gastric bypass, colectomy) or anatomical abnormalities precluding sleeve gastrectomy. * Active or uncontrolled chronic diseases (e.g., end-stage renal disease, cirrhosis, metastatic cancer, severe cardiovascular disease). * Psychiatric disorders limiting adherence to post-operative care (e.g., severe depression, psychosis, substance use disorder). * Pregnancy or breastfeeding (or plans for pregnancy within 12 months post-surgery). * Allergy or intolerance to surgical materials, anesthesia, or post-operative medications required for the study. * Inability to communicate or cooperate with study procedures (e.g., language barriers, cognitive impairment).

Design outcomes

Primary

MeasureTime frameDescription
The rate of patients with GERD at 24 months24 monthsThe main objective of the study was to evaluate the impact of Sleeve Gastrectomy procedure with a Nissen fundoplication (Nissen-Sleeve) on the rate of patients with GERD at 24 months.

Secondary

MeasureTime frame
Intra-operation incidentsPerioperative/Periprocedural
Hospital staysPerioperative/Periprocedural
Rate of re-interventiontwo-year
Surgery timePerioperative/Periprocedural
One-year Endoscopy findingOne-year
Early & Long term post-operative complicationtwo-year
Rate of re-hospitaltwo-year

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026